Sulfonamide compounds having 5-ht receptor activity

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/06 (2006.01) A61K 31/445 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 493/04 (2006.01)

Patent

CA 2275668

Compounds of formula (I) and pharmaceutically acceptable salts thereof in which A is methylene or -O-; B is methylene or -O-; g is 0, 1, 2, 3 or 4; U is an alkylene chain optionally substituted by one or more alkyl; Q represents a divalent group containing nitrogen atoms; and T represents an aryl or heteroaryl group, have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, Parkinson's disease, obesity, hypertension, Tourette's syndrome, sexual dysfunction, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, obsessive- compulsive behaviour, panic attacks, social phobias, eating disorders and anorexia, cardiovascular and cerebrovascular disorders, non-insulin dependent diabetes mellitus, hyperglycaemia, constipation, arrhythmia, disorders of the neuroendocrine system, stress and spasticity.

L'invention concerne les composés selon la formule (I), et des sels pharmaceutiquement acceptables de ces derniers dans lesquels A représente méthylène ou -O-; B représente méthylène ou -O-; g est égal à 0, 1, 2, 3 ou 4; U représente une chaine d'alkylène éventuellement substituée par un ou plusieurs alkyles; Q représente un groupe divalent contenant des atomes d'azote et T représente un groupe aryle ou hétéroaryle. Ces composés sont très utiles pour traiter des troubles du système nerveux central, par exemple, la dépression, l'anxiété, les psychoses (par exemple, la schizophrénie), la dyskinésie tardive, la maladie de Parkinson, l'obésité, l'hypertension, la maladie de Gilles de la Tourette, les difficultés sexuelles, la surconsommation de médicaments, la toxicomanie, les troubles cognitifs, la maladie d'Alzheimer, la démence sénile, les troubles obsessionels-compulsifs, les crises de panique, les phobies sociales, les troubles de l'alimentation et l'anorexie, les troubles cardiovasculaires et les troubles cérébrovasculaires, le diabète sucré non insulino-dépendant, l'hyperglycémie, la constipation, l'arythmie, les troubles du système neuroendocrinien, le stress et l'hypertonie spastique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sulfonamide compounds having 5-ht receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfonamide compounds having 5-ht receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide compounds having 5-ht receptor activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1788211

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.